Concepedia

Ken Yamaguchi

KY

179

Publications

11.8K

Citations

49

H-Index

1976

Active since

Affiliations

Kyoto University(Current)

Kindai University

National Cancer Research Institute

Shizuoka Cancer Center

Kyoto Medical Center

Ken Yamaguchi is an author at Kyoto University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1976–2024

179

Publications

179

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 <sup>+</sup> T lymphocytes are prognostic factors of human ovarian cancer

Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki et al. · Proceedings of the National Academy of Sciences · 2007 · 1.4K citations · Full text

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi et al. · British Journal of Cancer · 2015 · 689 citations · Full text

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng Jin, Junzo Hamanishi, Noriomi Matsumura et al. · Cancer Research · 2015 · 515 citations

, , +23

Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

Ken Yamaguchi, Masaki Mandai, Shinya Toyokuni et al. · Clinical Cancer Research · 2008 · 318 citations · Full text

Rows per page

1–5 of 179